Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

HUTCHMED (LSE:HCM): AstraZeneca files US NDA for ORPATHYS plus TAGRISSO in MET-driven lung cancer

HUTCHMED (China) Limited, which is quoted on AIM andNasdaqunder the ticker LSE:HCM and on the Hong Kong exchange under code 13, announced that AstraZeneca has filed aNew Drug Application (NDA)with the FDA for the combination of ORPATHYS and TAGRISSO.

Ankur Sharma | 30 September 2026

Why Is Proteome Sciences plc (LSE:PRM) Stock Up +3.93% on 29 September 2026?

•Proteome Sciences plc is being watched because a proteomics and life-sciences company providing contract research, biomarker and mass-spectrometry services for drug discovery and development.

Ankur Sharma | 30 September 2026

Why Is TheraCryf plc (LSE:TCF) Stock Up +2.94% on 29 September 2026?

•TheraCryf plc is being watched because a clinical-stage biotechnology company developing medicines for addiction and other neuropsychiatric disorders.

Ankur Sharma | 30 September 2026

Why Is NIOX Group plc (LSE:NIOX) Stock Up +3.66% on 29 September 2026?

•NIOX Group plc is being watched because a medical-device company focused on point-of-care fractional exhaled nitric oxide testing for asthma and COPD management.

Ankur Sharma | 30 September 2026

Why Is MicroSalt plc (LSE:SALT) Stock Up +3.57% on 29 September 2026?

•MicroSalt plc is being watched because a food-technology company commercialising patented low-sodium salt designed to deliver familiar salt flavour with materially reduced sodium.

Ankur Sharma | 30 September 2026

Ondine Biomedical (LSE:OBI) teams up with Mela to pilot Steriwave in NHS intensive care units

Ondine Biomedical Inc. (LSE:OBI) said on 29 September 2026 that it has entered a strategic data evaluationPartnershipwith Mela Solutions Ltd. The aim is to measure the financial and clinical impact of Steriwave across NHS intensive care units and to "verify Steriwave's cost-benefit ratio".

Ankur Sharma | 30 September 2026

Haleon PLC (LSE:HLN) Shares Fall 0.91% as JPMorgan Flags Negative Catalyst on Weak Sales Momentum

JPMorgan, which rates Haleon underweight, placed the stock on negative catalyst watch ahead of its third-quarter results, scheduled for 29 October. A negative catalyst watch indicates that the bank expects the upcoming results to be a disappointment that could weigh on the share price.

Ankur Sharma | 30 September 2026

Venture Life Group (LSE:VLG) reports £50.0m revenue with 16% organic growth; CFO Daniel Wells to become CEO

Venture Life published final results for the 17 months ended 31 May 2026, following a change in its accounting reference date from 31 December to 31 May. The comparative figures are for the 12 months to 31 December 2024, so the headline numbers are …

Ankur Sharma | 30 September 2026

Niox Group (LSE:NIOX) proposes £12.5m tender offer at 80p as half-year revenue slips 4.8%

NIOX Group (LSE:NIOX), which makes point-of-care FeNO testing devices used in the diagnosis and management of asthma and COPD, published interim results for the six months to 30 June 2026 and, in a separate announcement, a proposed tender offer.

Ankur Sharma | 30 September 2026

Why Is TheraCryf [LSE:TCF] in Focus After a 2.94% Rise?

•The company is developing a clinical and preclinical pipeline focused on brain disorders.

Ankur Sharma | 30 September 2026
Support

Hi! How can we help you today?

Loading…